Profound Medical Revenue Growth & History (PROF)
Profound Medical reported $16.1M in revenue for fiscal 2025, an increase of 65.28% from the previous fiscal year.
View full Profound Medical company overviewProfound Medical annual revenue and growth
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.1M | $6.4M | +65.28% |
| 2024 | 2024-12-31 | $9.7M | $3.8M | +65.11% |
| 2023 | 2023-12-31 | $5.9M | −$782,000 | −11.70% |
| 2022 | 2022-12-31 | $6.7M | −$192,000 | −2.79% |
| 2021 | 2021-12-31 | $6.9M | −$431,000 | −5.90% |
| 2020 | 2020-12-31 | $7.3M | $3.1M | +74.99% |
| 2019 | 2019-12-31 | $4.2M | — | — |
Profound Medical quarterly revenue
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.5M | $502,000 | +25.34% |
| Q1 2026 | 2026-03-31 | $5.3M | $3.0M | +127.98% |
| Q4 2025 | 2025-12-31 | $6.7M | $2.7M | +66.84% |
| Q3 2025 | 2025-09-30 | $5.1M | $2.5M | +99.02% |
| Q2 2025 | 2025-06-30 | $2.0M | $28,000 | +1.43% |
| Q1 2025 | 2025-03-31 | $2.3M | $1.1M | +92.04% |
| Q4 2024 | 2024-12-31 | $4.0M | — | — |
| Q3 2024 | 2024-09-30 | $2.5M | — | — |
| Q2 2024 | 2024-06-30 | $2.0M | — | — |
| Q1 2024 | 2024-03-31 | $1.2M | — | — |
Profound Medical revenue growth trends
Over the last five reported fiscal years, revenue grew from $7.3M to $16.1M, a compound annual growth rate of 17.12%. Profound Medical's latest reported quarter, Q2 2026, generated $2.5M in revenue, an increase of 25.34% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Profound Medical source filings ↗